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Résumé 
Une recrudescence des cas de syphilis a été observée ces dernières années. Son 
diagnostic clinique reste particulièrement difficile en l'absence de signe 
pathognomonique. Sur le plan oculaire elle présente un vaste spectre de 
manifestations diverses lui ayant valu le surnom de « la grande imitatrice ». Sa rareté 
et son hétérogénéité ont empêché l'identification et la vérification statistique des 
facteurs liés à un pronostic défavorable. Le but de cette étude a été d'explorer les 
paramètres cliniques et para-cliniques déterminant la sévérité et influençant 
l'évolution de la maladie. 
Ce travail comprend deux volets, la première partie intitulée : «Analysis of significant 
factors influencing visual acuity in ocular syphilis» publiée dans le British Journal of 
Ophthalmology a démontré qu'une mauvaise acuité visuelle initiale est associée de 
façon statistiquement significative à la sévérité de l'amputation du champ visuel, à la 
présence d'un cedème maculaire ou d'une neuropathie optique. Une amélioration de 
l'acuité visuelle grâce au traitement antibiotique est associée à la présence d'une 
vasculite (visible à l'angiographie fluorescéinique), d'une neurosyphilis ou d'une 
uvéite antérieure. Une récidive inflammatoire est fortement associée à une durée 
prolongée des symptômes avant l'introduction du traitement et à la présence de 
douleur comme signe d'appel. L'utilité clinique principale de ces résultats statistiques 
permet de conclure que les formes inflammatoires sévères associées à la triade 
(vasculite, neurosyphilis et uvéite antérieure) constituent un phénomène réversible 
pour autant qu'un traitement précoce et adéquat ait été introduit. 
Le deuxième volet de l'étude analyse les manifestations angiographiques (à la 
fluorescéine (AF) et au vert d'indocyanine (AICG)) de la syphilis oculaire et a été 
publié dans le journal du Graefes Archives of Clinical and Experimental 
Ophthalmology sous le titre suivant : "Fluorescein and indocyanine-green 
angiography in ocular syphilis: an exploratory study". Des associations faibles ont été 
démontrées entre la présence d'une vasculite lors de AF et d'une uvéite antérieure, 
d'une hyalite et d'un âge plus jeune. Une association forte est identifiée entre la 
présence des «dark dots» sur l'AICG et d'une uvéite antérieure ainsi qu'entre la 
présence des «hot spots» sur l'AICG et d'une durée prolongée des symptômes. Les 
conclusions d'importance clinique significative lors de la syphilis oculaire sont que 
les« dark dots »ou hypofluorescences en AICG évoquent la présence d'une atteinte 
inflammatoire oculaire sévère et que les« hot spots »ou hyperfluorescences en AICG 
sont significatifs d'une atteinte chronique. 
Cette étude contribue à modifier les attitudes cliniques lors de la syphilis oculaire 
surtout en ce qui concerne l'urgence à traiter afin d'assurer une récupération optimale. 
Elle aide aussi à redéfinir le rôle de l'angiographie dans la syphilis oculaire pour 
déterminer la sévérité, la durée de la maladie ainsi que le pronostic visuel. 
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Introduction 
Syphilis constitutes a rare cause of ocular inflammation accounting for 0.1 % of 
patients evaluated in a general ophthalmology clinic and 2.5% of patients in a referral 
practice [1, 2]. It has been described as the "great imitator" reflecting its vast range of 
clinical manifestations and the lack of any pathognomonic ocular signs that could lead 
to its diagnosis. The increased prevalence of this ocular affliction in recent years, 
which has been associated with the emergence of HIV infection [3, 4], has led to 
renewed interest in research aiming at its earlier diagnosis and effective treatment. 
Controversy exists regarding the applicability of the traditional classification of 
syphilis in the context of ocular inflammation [5]. Other grey areas in the 
management of ocular syphilis include indications for performing lumbar puncture, 
the efficacy of alternative treatment regimens and the role of angiography [6]. 
Objectives 
Main objective of this research project was providing answers to specific questions 
regarding diagnosis and management of ocular syphilis. 
More specifically we attempted to identify statistical associations between 
demographic, clinical and laboratory parameters at the moment of initial diagnosis of 
the disease; to determine the sensitivity of lumbar puncture for the diagnosis of 
neurosyphilis in the context of ocular inflammation[7]; to assess the efficacy of a 
classic treatment regimen of intravenous penicillin for ocular syphilis and to compare 
it with an alternative regimen of ceftriaxone[8]; to clarify the role of corticosteroids 
and immunosuppressors in the management of ocular syphilis; to describe patterns of 
visual field alterations associated with ocular syphilis; and to identify potential risk 
factors for a recurrence of the disease after adequate treatment. 
A particular focus of the study concerned the identification of angiographie patterns 
specific to ocular syphilis both on fluoresceine (FA) and on indocyanine green 
angiography (ICGA). The role of indocyanine green angiography in the diagnosis and 
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assessment of response to treatment of other types of granulomatous uveitis have been 
studied in the past [9-11]. However its usefulness in revealing the extent of choroidal 
inflammation in ocular syphilis has not been thoroughly evaluated, possibly reflecting 
the rarity of the disease. There is only one study in the literature based on a small 
number of cases attempting to elucidate the characteristic findings of ocular syphilis 
on indocyanine green angiography [12]. In our study we attempted to describe the 
angiographie patterns observed on indocyanine green angiography in ocular syphilis, 
compare them with the corresponding fluoresceine angiography findings and assess 
their evolution after treatment. Furthermore, we aimed at exploring any meaningful 
statistical associations between specific angiographie manifestation and severity of 
disease presentation, as well as disease evolution after treatment. 
Material and Methods 
26 patients with ocular syphilis were followed in the context of a referral practice for 
ocular immunology and infection between 1999 and 2009. The diagnosis of ocular 
syphilis was based on at least one positive treponemal serologic test and the exclusion 
of other conditions that could account for the ophthalmic manifestations. Patient 
follow-up was performed with great homogeneity, by the same ophthalmologist and 
in accordance with international criteria (IUS6 and the 2005 classification). 23 of the 
patients underwent dual fluorescein and indocyanine green angiography, using a 
standard angiographie protocol for ocular inflammation [13]. At least one lumbar 
puncture was performed at 20 of the patients. All patients received antibiotic 
treatment for neurosyphilis, either with a standard regimen of intravenous penicillin or 
with an alternative regimen of ceftriaxone, in accordance with international 
recommendations. For several patients with persistent ocular inflammation the 
administration of systemic corticosteroid or immunosuppressive treatment was 
deemed necessary. Most patients were evaluated over a prolonged period oftime in 
consecutive follow-up visits. 
The data for the study were collected retrospectively from the files kept at the 
"Hôpital Ophtalmique Jules Gonin" and the "Centre Hospitalier Universitaire 
Vaudois". A cross-sectional analysis was performed for demographic, clinical, 
laboratory and angiographie findings at the moment of first diagnosis, in search of 
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statistically significant correlations between these parameters. Statistical associations 
were also investigated between initial parameters and response to treatment, 
recurrence of ocular inflammation and evolution of angiographie findings. The pattern 
and prevalence of angiographie findings was particularly studied, attempting to 
determine the extent of retinal and choroidal involvement in the ocular inflammation. 
Results and published articles 
Faced with a wealth of meaningful associations we opted for dividing the work in two 
stages, one focusing on whether statistical associations can be demonstrated in ocular 
syphilis between baseline clinical and laboratory parameters with visual acuity at 
presentation and with any change in visual acuity after treatment and the other aiming 
at describing angiographie patterns encountered in the context of ocular syphilis, and 
exploring any statistical associations between the angiographie manifestations and 
baseline parameters as well as evolution after treatment. The former section of the 
research resulted in the publication of the article entitled "Analysis of significant 
factors influencing visual acuity in ocular syphilis" in the British Journal of 
Ophthalmology. Out of several associations observed, the following factors were 
associated with worse initial visual acuity in patients with ocular syphilis: severity of 
visual field impairment at presentation (p=0.012), macular oedema (p=0.004) and 
optic neuropathy (p=0.031 ). There was a borderline association with the presence of 
vasculitis on fluroangiography (p=0.072). Improvement in best corrected visual acuity 
after treatment was significantly associated with the presence of vasculitis on 
fluroangiography (p=0.005), neurosyphilis, according to lumbar puncture findings 
(p=0.037) and marginally with anterior uveitis (p=0.070). Inflammation relapse was 
associated with the coexistence of pain as presenting sign (p<0.001) and with a longer 
duration of symptoms prior to the initial visit (p=0.023). The latter stage of the 
research focusing on angiographie findings in ocular syphilis resulted in the 
publication of the article entitled "Fluorescein and indocyanine-green angiography in 
ocular syphilis: an exploratory study" in the journal Graefes Archives of Clinical and 
Experimental Ophthalmology. The features most frequently observed in fluorescein 
angiography were retinal staining of focal punctate retinal lesions (43.5%), followed 
by staining of retinal vessels, mainly veins (30.4%) and dise hyperfluorescence 
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(30.4%). Indocyanine-Green Angiography features could be classified into three main 
patterns. The first pattern consisted of hypofluorescent choroidal lesions, visible from 
the early and intermediate phases of the angiogram onwards, which either became 
isofluorescent in the late phases, or remained hypofluorescent (dark dots) and were 
o bserved in 13 patients ( 5 9 .1 % ) The second pattern corresponded to scattered 
hyperfluorescent spots (hot spots) appearing in the late phases of the angiogram, in 
the mid-periphery and/or the posterior pole present in 11 patients (50%). The third 
pattern was fuzzy choroidal vessels with leakage from the intermediate phase of the 
angiogram onwards in five patients (14.7%). As regards observed statistical 
associations, the presence of any dark dots in ICGA was significantly associated with 
anterior uveitis (p=0.031). The presence of hot spots in ICGA was significantly 
associated with longer duration of symptoms prior to initial visit (p=0.032) and with 
male gender (p=0.012). Weak non-significant trends were found associating vascular 
staining in FA with anterior uveitis (p=0.066), vitritis (p=0.069), and younger age 
(p=0.061), as well as dise hyperfluorescence in FA with seropositivity for HIV 
(p=0.089) and macular edema in FA with longer disease duration (p=0.061). The 
presence of any darlc dots in ICGA exhibited a weak trend of association with anterior 
uveitis and/or vitritis (p=0.079). 
Conclusions 
The foremost conclusion of the article relating to baseline parameters and initial 
disease severity with significant clinical significance was that the triad of 
neurosyphilis, anterior uveitis and vasculitis on fluroangiography appears to be 
associated with improvement in visual acuity after treatment. Interpreting this striking 
finding we argue that severe ocular inflammation in the context of ocular syphilis, as 
indicated by the presence of anterior uveitis, vasculitis or vitritis, does not have 
permanent visual repercussions when appropriately treated. Our findings suggest that 
in the context of ocular syphilis, vasculitis, anterior uveitis and neurosyphilis are 
indicative of active, albeit reversible inflammation that responds to proper treatment, 
thus explaining the improvement observed in visual acuity. On the other hand, 
irreversible loss in BCV A in the present study occurred in patients with long-standing 
serous retinal detachment involving the macula and in patients with optic atrophy 
following syphilitic optic neuropathy. Another clinically relevant conclusion of this 
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research was that although early treatment of ocular syphilis will lead to a good visual 
prognosis, a delay in therapy may result in severe ocular complications. Consistent 
with this statement, the group of patients with inflammation recurrence in our series 
presented considerably later than the rest in a statistically significant manner, 
reflecting either an inappropriate initial management or chronic neglect. In our series, 
there was no statistically significant difference in visual outcome according to the 
treatment between the two groups of patients, one treated with a classic regimen of 
intravenous penicillin and the other with a regimen of intravenous ceftriaxone 
signifying that the latter may be a reasonable alternative to penicillin in the treatment 
of ocular syphilis. 
As regards the second arm of the research relating to angiographie manifestations in 
ocular syphilis and their clinical significance, we highlighted several trends of 
association between vascular staining in FA and worse visual acuity at presentation, 
improvement in visual acuity after treatment, anterior uveitis, vitritis and younger age 
at presentation. The findings implicating vascular staining may point to a close 
association between these markers of active inflammation, indicating that eyes with 
vascular staining are more severely inflamed, which in tum may account for the weak 
trend towards worse BCV A at baseline in these patients. The high rate of 
disappearance of vascular staining in FA performed after treatment indicates that 
vasculitis in ocular syphilis is not accompanied by permanent visual repercussions 
when properly treated. As far as ICGA manifestations are concerned, we concluded 
that similar patterns in ICGA to those observed in our series have been described in 
other forms of granulomatous posterior uveitis, such as sarcoidosis and tuberculosis. 
Our study revealed a significant association between presence of darlc dots in ICGA 
and anterior uveitis, and a weak trend of association with presence of anterior uveitis 
and/or vitritis. We suggest that the presence of dark dots, excluding those associated 
with atrophy, may signify active granulomatous posterior choroidal inflammation. 
With regards to hot spots in ICGA, the lack of association between hot spots and any 
ocular manifestation with important functional repercussions, such as macular edema, 
optic neuropathy, or anterior uveitis, may reveal an exclusively choroidal origin of 
these angiographie features. On the other hand, the identified association between 
presence of hot spots and a longer duration of symptoms prior to the first visit may 
render this angiographie finding indicative of long-standing disease. 
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Future perspectives 
The meaningful contribution of this work on clinical attitudes towards ocular syphilis 
resides in the realisation of the reversible nature of the condition provided that 
adequate and timely treatrnent is adrninistered. This conclusion rnay help increase the 
level of clinical suspicion for ocular syphilis in the face of granulomatous ocular 
inflammation and introduce a sense of urgency for appropriately treating this disease 
and thus ensuring the best possible outcorne for patients. Prompt treatment enables a 
good visual prognosis, while any delay in therapy increases the risk of subsequent 
relapse and this principle should guide therapeutic decisions. Our work on 
angiographie manifestations of ocular syphilis led to the conclusion that both 
fluorescein and indocyanine-green angiography can offer valuable info1mation 
concerning disease severity and duration, and can even contribute some clues to 
disease prognosis and therefore constitute useful tools in the hands of the ocular 
inflammation specialists. As in any clinical research and especially in the context of a 
condition characterised by significant rarity and heterogeneity further corroborative 
studies would serve to confirm the findings presented in this project. 
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Analysis of significant factors influencing visual acuity 
in ocular syphilis 
Konstantinos Balaskas, 1 Theodoros N Sergentanis, 2 Stefano Giulieri, 3 
Yan Guex-Crosier 1 
ABSTRACT 
Background The aim of this study is to determine 
whether statistical associations can be demonstrated in 
ocular syphilis between baseline clinical and laboratory 
parameters with visual acuity at presentation and with 
any change in visual acuity after treatment. 
Methods Charts of 26 patients (42 eyes) with ocular 
syphilis presenting to the Uveitis clinic of the Jules-Gonin 
Eye Hospital were reviewed. A baseline cross-sectional 
analysis was performed in order to identify any 
association between visual acuity at presentation and 
demographic, clinical or laboratory parameters. After 
treatment, any analogy between these parameters and 
a change in visual acuity was subsequently assessed in 
a series of univariate comparisons. 
Results The following factors were associated with 
worse initial visual acuity: severity of visual field 
impairment at presentation (p=0.012). macular oedema 
(p=0.004) and optic neuropathy (p=0.031 ). There was 
a borderline association with the presence of vasculitis 
on fluroangiography (p=0.072). lmprovement in best 
corrected visual acuity after treatment was significantly 
associated with the presence of vasculitis on 
fluroangiography (p=0.005), neurosyphilis, according to 
lumbar puncture findings (p=0.037) and marginally with 
anterior uveitis (p=0.070). Inflammation relapse was 
associated with the coexistence of pain as presenting 
sign (p<0.001) and with a longer duration of symptoms 
prior to the initial visit (p=0.023). 
Conclusions Severe ocular inflammation associated 
with vasculitis, vitritis or anterior uveitis in ocular syphilis 
would appear to be a reversible phenomenon that 
responds well to appropriate antibiotic treatment, 
resulting in improvement in visual acuity. Prompt 
treatment enables a good visual prognosis, while any 
delay in therapy increases the risk of subsequent relapse. 
INTRODUCTION 
Ocular syphilis accounts for approximately 0.1 % of 
patients presenting to a general ophthalmology 
clinic and 2.5% of all uveitis cases reported in 
a reference practice for ocular inflammation. 1 2 
There being no typical clinical presentation, ocular 
syphilis may be included in the differential diag-
nosis of any form of ocular inflammation, justi-
fying its inclusion among the so-called masquerade 
syndromes.3 4 
The re-emergence of ocular syphilis in recent 
years has excited renewed interest for this ancient 
disease.5- 7 Previous investigators have described 
several ocular manifestations of syphilis, including 
optic neuritis, anterior uveitis, vitritis, chorior-
etinitis, vasculitis and serous retinal detachment8 
and emphasised the relative frequency of such 
manifestations. Other key issues in the relevant 
literature include the role of lumbar puncture in 
ocular syphilis and the superiority of a classic treat-
ment regimen for neurosyphilis with intravenous 
penicillin G.9 
To date there has been no comprehensive statis-
tical approach aiming to identify factors determi-
nant in the severity of the initial presentation of 
ocular syphilis, nor has there been any attempt 
to associate baseline parameters with clinical 
evolution. 
The purpose of this paper is to analyse statistical 
associations between visual acuity at presentation 
and demographic, ocular and laboratory parameters 
at baseline, as well as to identify baseline factors 
significantly associated with changes in visual 
acuity after treatment. Descriptive statistics drawn 
from collected data are also presented. 
METHODS 
A retrospective review was carried out on the 
charts of 34 consecutive patients presenting, 
between January 1999 and December 2009 at the 
uveitis clinic of the Jules-Gonin Eye Hospital, with 
ocular inflammation and a positive treponemal 
serological test for syphilis. Inclusion criteria for 
this study were signs of uveitis compatible with 
ocular syphilis on clinical evaluation, together with 
a positive treponema pallidum haemagglutination 
assay (TPHA) or fluorescent treponemal antibody 
absorbed (FTA-Abs) test. Medical history and 
serology for each patient were discussed with an 
infectious disease specialist (SG). In early syphilis, 
venereal disease research laboratory (VDRL) test 
was considered as truly positive in the absence of 
any other disease that could be at the origin of 
false-positive results (systemic lupus eryth-
ematosus, rheumatoid arthritis, Lyme disease) and 
was completed by TPHA and FTA-Abs serology. In 
late syphilis, a positive TPHA or FTA-Abs was 
considered sufficient to make the diagnosis. False-
positive serology due to cross-reactivity in the 
context of Lyme disease was excluded by a negative 
ELISA test for Borreliosis and a negative western 
blot test. None of the patients included in the study 
had a prior history of ocular inflammation, thus it 
was assumed that the presenting episode consti-
tuted the first in their history of ocular syphilis. 
The presence of other ocular morbidities in eight 
patients led to their exclusion from further study. 
Al! patients were followed by the same uveitis 
specialist (YGC) and according to official recom-
mendations laid down for the management of 
ocular syphilis.10 Initial evaluations for all patients 
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included fluorescein angiography and indocyanine green angiog-
raphy, according to a standard protocol for posterior uveitis, 11 
octopus static perimetry, treponemal and non-treponemal 
serology for syphilis and lumbar puncture to identify neuro-
syphilis. Diagnosis of neurosyphilis was defined as the presence of 
a positive VDRL (> 1) and/or 5 or more white blood cells per ml or 
increased protein in cerebrospinal fluid ((CSF) normal range 
15-45 mg/dl), each supporting the diagnosis of neurosyphilis. 
Treatment consisted of either a standard regimen of intrave-
nous penicillin for neurosyphilis at a dose of 6X4 MU per day for 
14 days, or an alternative regimen of intravenous ceftriaxone at 
a dose of 2 g per day for 14 days. At the end of treatment, the 
same laboratory and angiographie evaluations as those 
performed at baseline were repeated. 
Eye-based statistical analysis was preferred, given that the 
main factor (logarithmic minimal angle resolution (logMAR)) 
pertained to each eye. Because of the weak correlation of best 
corrected visual acuity (BCVA) between right and left eyes in 
cases of bilateral involvement, as calculated by Spearman's rank 
correlation coefficient, no adjustment for inter-eye correlation 
was performed (see the section on Results). 
After calculating descriptive statistics, we performed a cross-
sectional analysis at baseline. BCVA (logMAR scale) was set as 
the main factor for the cross-sectional analysis that is, the 
association between visual acuity, and all demographic, clinical 
or laboratory parameters were evaluated. 
In order to determine the factors associated with disease 
evolution, two outcomes were assessed: first concerning visual 
acuity, an ordinal variable was created to describe changes in 
visual acuity after the completion of treatment (0: deterioration, 
1: stability, 2: improvement). Second, concerning relapse after 
treatment, any recurrence of inflammation was recorded. The 
associations between each outcome and all registered demo-
graphic, clinical or laboratory parameters were assessed in 
a series of univariate comparisons. Associations were also sought 
between the individual clinical parameters at baseline. 
Concerning visual field impairment, the scale of severity was 
attributed on the basis of mean deviation (MD) values. Visual 
field loss was accordingly classified as normal (MD2:-2 decibels 
[dB]), mild (-6 dB<MD<-2 dB), moderate (-12 dB<MD<-6 
dB), severe (-18 dB<MD<-12 dB) and very severe (MD:S-18 
dB). For purposes of statistical analysis, a post hoc merging of 
categories was subsequently performed; data were presented as 
severe/very severe versus normal/mild/moderate impairment. 
Pearson's X2, Fisher's exact test and Mann-Whitney-Wilcoxon 
(MWW) test for independent samples were appropriately 
applied. The performance of non-parametric statistics regarding 
BCVA (logMAR scale) was necessitated due to a marked devia-
tion from normality, as evidenced from Kolmogorov-Smirnov 
and Shapiro-Wilk tests. The level of statistical significance was 
set to p<0.05. However, results of borderline significance 
(0.10<p<0.05) were also provided, given that they may become 
significant in the context of a larger sample. 12 Taking into account 
the small sample size, no multivariate analysis was performed. 
Statistical analysis was performed with STATA 8.0 statistical 
software (Stata Corporation, College Station, Texas, USA). 
Institutional Review Board /Ethics Committee approval of 
the University of Lausanne was obtained. Described research 
adhered to the tenets of the Declaration of Helsinki. 
RESULTS 
Patient-based features of the study sample are presented in 
table 1. The 26 patients included in the study had a median age 
of 45 years. There were 18 men and 8 women. Four patients 
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Table 1 Demographic, clinical and laboratory features of the study 
sample. Patient-based descriptive statistics (n=26) 
Continuous variables Median (range) 
Age (years) 45 (33-80) 
Duration of symptoms before the first visit (days) 
Follow-up (months) 
60 (0 to more than 10 years) 
10 (0-68) 
Categorical and ordinal variables 
Male sex 
Calling sign-related parameters 
Bilateral ophthalmic syphilis 
Calling sign 
Sudden drop in visual acuity 
Progressive drop in visual acuity 
Drop in visual acuity (not specified) 
Myodesopsias 
Pain as only symptom 
Symptoms of uveitis evolving chronically 
Argyll-Robertson pupils 
Asymptomatic 
Coexistence of pain as a calling sign 
Syphilis and HIV history 
History of systemic signs of syphilis 
Known syphilis 
Recall of chancre 
HIV infection 
Primary syphilis 
Secondary syphilis 
Tertiary syphilis 
Neurosyphilis 
Findings of lumbar puncture 
Positive VDRL (total n= 18) 
Positive TPHA (total n= 19) 
Positive FTA-lgG (total n=8) 
T reatment-related parameters 
Type of antibiotic (total n=23) 
lntravenous penicillin G 
Ceftriaxone 
Administration of systemic corticoids (total n=23) 
Administration of immunosuppressive agents (total n=23) 
Relapse alter treatment (total n=23) 
Reaction Jarisch-Herxheimer (total n=23) 
n (%) 
18 (69.2) 
16 (61.5) 
12 (46.2) 
5 (19.2) 
2 (7.7) 
2 (7.7) 
1 (3.8) 
2 (7.7) 
1 (3.8) 
1 (3.8) 
10 (38.5) 
8 (30.8) 
10 (38.5) 
7 (26.9) 
2 (7.7) 
0 (0.0) 
3 (11.5) 
23 (88.5) 
15 (57.7) 
1 {5.5) 
11 (57.9) 
2 (25.0) 
15 (65.0) 
8 (35.0) 
11 (48.0) 
2 (8.7) 
4 (17.4) 
2 (8.7) 
FTA, fluorescent treponemal antibody; TPHA, treponema pallidum haemagglutination assay; 
VDRL, venereal disease research laboratory test. 
were African, 1 was Asian and 21 Caucasian. Sixteen patients 
had bilateral ocular involvement and 10 unilateral. Seven 
patients recalled the presence of a chancre at some point in the 
past, eight reported a history of systemic signs of syphilis 
consisting of a cutaneous eruption of the palms and trunk and 
four had systemic signs of syphilis at presentation (one patient 
had a cutaneous eruption, two had central nervous system 
involvement and one suffered from syphilitic aortitis). Of the 
10 patients who had a diagnosis of syphilis in the past, 6 
reported having been treated with an indeterminate number of 
intramuscular injections of penicillin. 
Fifteen patients had a diagnosis of neurosyphilis by lumbar 
puncture findings. VDRL analysis in CSF was positive only in 
one patient, CSF cell count ranged between 0 and 153, with 
a median of 12, whereas CSF protein ranged from 30 to 
1000 mg/dl with a median of 464 mg/dl. Fourteen patients 
(53.8%) had a positive VDRL (> 1) in the serum, ranging up to 
2048, while all patients had positive TPHA and FTA-Abs. 
The most frequent ocular manifestations are prcsented in 
table 2. Mean BCVA at prescntation (logMAR) was 0.62±0.78. 
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Table 2 Clinical manifestations of ophthalmic syphilis in 
the study sample. Eye-based statistics (n=42) 
Continuous variables Mean±SD 
BCVA at presentation (logMAR) 0.62±0.78* 
BCVA at the end of follow-up (logMAR) 0.29±0.57* 
Categorical and ordinal variables n (%) 
RAPD 3 (7.1) 
Optic neuropathy 13 (31.0) 
Anterior uveitis 19 (45.2) 
Vitritis 21 (50.0) 
Retinitis 29 (69.1) 
Macular oedema 8 (19.1) 
Vasculitic signs 11 (26.2) 
Retinal haemorrhage 4 (9.5) 
Serous retinal detachment 4 (9.5) 
Scleritis 2 (4.8) 
*At the end of follow-up, a statistically significant improvement in BCVA 
was achieved (p=0.001, Wilcoxon matched-pairs signed ranks test). 
BCVA, best corrected visual acuity; logMAR, logarithmic minimal angle 
resolution; RAPD, relative afferent pupillary defect. 
BCVA at presentation below the threshold for legal blindness 
(2:1 on the logMAR scale) was observed in 28.6% of the involved 
eyes (12 of 42). Of the cases with posterior involvement, 45.2% 
had concomitant anterior chamber inflammation, but no case of 
isolated anterior uveitis was observed. One patient had a diag-
nosis of unilateral choroidal neovascularisation; one presented 
with unilateral peripheral temporal retinal neovascularisation; 
there was one case of bilateral giant retinal tears and consequent 
retinal detachment following a Jarisch-Herxheimer reaction to 
treatment with penicillin; one patient developed unilateral 
central retinal vein occlusion. 
Fifteen patients underwent treatment with a regimen of 
penicillin and eight with a regimen of ceftriaxone within 1 
month of initial presentation. Administration of systemic 
steroids was deemed necessary in 11 patients, at an initial dose 
of 1 mg/kg/day and consequent adaptation according to the 
response. Of these patients, six had persistent vitritis, three had 
cystoid macular oedema, one had extensive vasculitis and one 
had persistent papillitis. Mean BCVA at the end of follow-up 
was 0.29±0.57. Improvement in BCVA after treatment was 
statistically significant (p=0.001). Of the 22 eyes that exhibited 
improvement in BCVA after treatment, 13 gained more than 
three lines (each line on the standardised visual acuity chart 
increasing by 0.1 log units), nine of these gained more than four 
lines. Deterioration in BCVA after treatment was observed in 
15.8% of the involved eyes (6 of 38), with one presenting a loss 
of more than two lines. In all these cases, BCVA remained below 
the threshold for legal blindness. Of the six eyes concerned, three 
had optic neuropathy, two had serous retinal detachment 
involving the macula and one had central retinal vein occlusion. 
Four patients, after an initial favourable response to treatment, 
presented with a recurrence of ocular inflammation between 
3 months and 1 year after the end of treatment. We were able to 
exclude the possibility of a re-infection or a poor response to 
treatment in these four patients by monitoring VDRL; this 
remained negative in three cases and exhibited a fourfold 
decrease in titre in one case. Of these patients, three presented 
with a relapse of vitritis and chorioretinitis and one exhibited 
a recurrence of anterior uveitis with hypopyon. Al! four patients 
received a new treatment cycle with oral prednisone. 
In patients with bilateral impairment in visual acuity, the 
correlation between BCVA of the right and left eyes was weak 
and far from reaching forma! statistical significance (r=0.367, 
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p=0.240). Consequently, eye-based statistical analyses were not 
controlled for inter-eye relationships in patients with bilateral 
ocular involvement. 
The factors significantly associated with visual acuity at 
baseline are presented in table 3. Statistically significant associ-
ations were demonstrated between poor visual acuity and 
the following: female gender (p=0.03); severity of visual 
field impairment at presentation (p=0.012); macular oedema 
(p=0.004); optic neuropathy (p=0.031) and a borderline associ-
ation with the presence of vasculitis on fluroangiography 
(p=0.072, difference: 0.28, 95% CI: -0.31 to 0.86). Worthy of 
note, severity of visual field impairment was marginally associ-
ated with vitritis (p=0.053, MWW, yielding difference: 0.57, 95% 
CI: 0.15 to 2.51). 
Factors significantly associated with modification in BCVA 
after treatment are presented in table 4. Improvement in BCVA 
was associated with the presence of vasculitis on fluroangiog-
raphy (p=0.005) and neurosyphilis, according to lumbar punc-
ture findings (p=0.037); there was a borderline association with 
anterior uveitis (p=0.070, difference in percentages: +34.4%, 
95% CI: +4.4% to +64.4%). These three parameters were also 
statistically associated with each other. More specifically, 
neurosyphilis was associated with vasculitis on fluroangiog-
raphy (p=0.020, Fisher's exact test) and with anterior uveitis 
(p=0.025, x2 test); vasculitis on fluroangiography was associated 
with anterior uveitis (p=0.019, Fisher's exact test). Vasculitis on 
fluroangiography was also associated with vitritis (p=0.003, 
Fisher's exact test). Presence of macular oedema at baseline did 
not correlate with either deterioration or improvement in BCVA 
after treatment (p=0.111, Mann-Whitney-Wilcoxon test). Of 
the eight eyes with this clinical manifestation, seven exhibited 
improvement in BCVA after treatment. Change in visual acuity 
was not associated with the choice of antibiotic treatment 
(p=0.498, MWW). However, the choice of antibiotic treatment 
administered was significantly associated with baseline BCVA 
(p=0.008, MWW). 
Table 3 Factors significantly associated with BCVA (logMAR) at 
presentation. Eye-based analysis (n=42) 
Sex 
Male (n=271 
Female (n=15) 
Severity of visual field impairment 
NormaVmild/moderate (n= 10) 
Severe/very severe (n=15) 
Vasculitis in fluroangiography 
Yes (n=9) 
No (n=27) 
Macular oedema 
Yes (n=8) 
No (n=34) 
Optic neuropathy or RAPD 
Yes (n=14) 
No (n=28) 
Recall of chancre 
Yes (n=l 1) 
No (n=31) 
Type of antibiotic treatment subsequently 
administered 
lntravenous penicillin G 
Ceftriaxone 
Mean±SD 
baseline BCVA p 
0.49±0.78 
0.85±0.74 
0.15±0.18 
0.85±0.78 
0.83±0.74 
0.55±0.76 
1.32±0.89 
0.45±0.66 
0.97±0.81 
0.44±0.71 
0.91 ±0.74 
0.51±0.77 
0.95±0.84 
0.25±0.38 
0.030MWW 
O.Q12MWW 
0.072MWW 
0.004MWW 
0.031MWW 
O.ü12MWW 
o.oo8Mww 
MWWP value derived !rom Mann-Whitney-Wilcoxon test for independent samples. 
BCVA, best corrected visual acuity; RAPD, relative afferent pupillary defect. 
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Table 4 Factors significantly associated with the change in BCVA after 
treatment. Eye-based analysis (n=38). Percentages are given with 
100%, corresponding to each row. 
Deterioration No change lmprovement 
in BCVA in BCVA in BCVA 
Freq {%) Freq (%) Freq (%) p 
Vasculitis in fluroangiography 0.005MWW 
Yes (n=9) 0 (0.0) 0 (0.0) 9 (100.0) 
No (n=25) 5 (20.0) 9 (36.0) 11 (44.0) 
Neurosyphilis 0.037MWW 
Yes (n=19) 3 (15.8) 1 (5.3) 15 (79.0) 
No (n=17) 2 (11.8) 9 (52.9) 6 (35.3) 
Anterior uveitis 0.070MWW 
Yes (n=17) 2 (11.8) 2 (11.8) 13 (76.4) 
No (n=19) 3 (15.8) 8 {42.1) 8 (42.1) 
Retinal participation* 0.097MWW 
Yes (n=31) 4 (12.9) 7 (22.6) 20 (64.5) 
No (n=5) 1 (20.0) 3 (60.0) 1 (20.0) 
Type of antibiotic treatment 0.498MWW 
lntravenous penicillin 4 (17.0) 3 (13.0) 16 (70.0) 
G (n=23) 
Ceftriaxone (n=13) 1 (7.6) 5 (38.4) 7 (54.0) 
MWWP value derived !rom Mann-Whitney-Wilcoxon test for independent samples. 
*Defined as any of the following constituants: ratinitis, macular oedema, ratinai detachment 
and ratinai haemorrhage. 
BCVA, best corrected visual acuity. 
Recurrence of inflammation after initial remission following 
proper antibiotic treatment was associated with the coexistence 
of pain as a presenting sign (p<0.001, Fisher's exact test) and 
with a longer duration of symptoms prior to the initial visit 
(p=0.023, MWW). Coexistence of pain as a presenting sign was 
also associated with anterior uveitis (p=0.023, Fisher's exact test). 
DISCUSSION 
Baseline factors statistically associated with visual acuity at 
presentation have not previously been described in the context 
of ocular syphilis. In our study, poorer visual acuity at presen-
tation was associated with female gender, macular oedema, 
optic neuropathy and the presence of vasculitis on fluorescein 
angiography. Furthermore, poor visual acuity was associated 
with the severity of visual field impairment at presentation. 
Associations between baseline parameters and change in 
visual acuity after treatment have not been previously identified 
in ocular syphilis. The triad of neurosyphilis, anterior uveitis and 
vasculitis on fluroangiography appears to be associated with 
improvement in visual acuity after treatment. These three 
parameters are closely interrelated with each other, further 
reinforcing their joint importance in predicting disease evolu-
tion. Vasculitis on fluorescein angiography is further associated 
with vitritis, another marker of active ocular inflammation. 
We argue that severe ocular inflammation in the context of 
ocular syphilis, as indicated by the presence of anterior uveitis, 
vasculitis or vitritis, does not have permanent visual repercus-
sions when appropriately treated. Central nervous system 
involvement and vasculitis have been identified as negative 
prognostic indicators for visual acuity in ocular Behçet, revealing 
the occlusive-ischaemic aspect underlying the pathophysiology 
of this disease. 13 Our findings, however, suggest that in the 
context of ocular syphilis, vasculitis, anterior uveitis and 
neurosyphilis are indicative of active, albeit reversible inflam-
mation that responds to proper treatment, thus explaining the 
improvement observed in visual acuity. On the other hand, 
irreversible Joss in BCVA in the present study occurred in 
patients with long-standing serous retinal detachment involving 
Br J Ophtha!ma/ 2011 ;95:1568-1572. doi:10.1136/bjo.2010.194498 
the macula and in patients with optic atrophy following syph-
ilitic optic neuropathy. BCVA in eyes with macular oedema at 
presentation tented to improve after treatment, though the 
association did not reach statistical significance. 
In accordance with Beck et al, 14 we preferred to use an ordinal 
variable expressing any change in logMAR as primary outcome, 
instead of creating a binary variable based on whether or not 
there has been a particular worsening in visual acuity of three or 
more lines. Given the small study sample, this elaborate 
approach maximised the information gained from the data and 
enabled accommodating, instead of overlooking, subtle changes 
concerning both improvement and deterioration of acuity. We 
acknowledge that our method does not take into account the 
magnitude of improvement, which, nevertheless, was in most 
cases significant, further reinforcing the reliability of the 
obtained statistical associations. 
We considered the resurgence of inflammation after initial 
remission as a principally immune-mediated reaction, rather 
than a failure of treatment for syphilitic infection, and we 
managed it accordingly. Based on the evolution of serum VDRL 
titres, the possibilities of re-infection or treatment failure were 
excluded by an infectious disease specialist. Similar cases are 
reported in the literature, specifically a case of development of 
cystoid macular oedema after the resolution of inflammation 
that responded to intravitreal triamcinolone.15 This was also 
observed in one patient in the series reported by Browning,9 
cases 4 and 5 in that of Halperin et a/16 and in the case reported 
by Currie et a/17 A pattern that arises from the study of such 
cases is that, although an early treatment of syphilis will lead to 
a good visual prognosis, a delay in therapy may result in severe 
ocular complications.18 Consistent with this statement, the 
group of patients with inflammation recurrence in our series 
presented considerably later than the rest in a statistically 
significant manner, reflecting either an inappropriate initial 
management or chronic neglect. Another common characteristic 
that stands out in this group of relapsing patients is the coex-
istence of pain as a presenting sign, which in turn is associated 
with the presence of anterior uveitis. This finding, albeit 
statistically significant, is rather more difficult to interpret, 
possibly painting to a more intense, persistent inflammatory 
response already present at the onset of ocular syphilis. 
Our study confirms the less-than universal finding of 
abnormal CSF in the context of ocular syphilis (57.7%). Given 
that the ocular involvement in the context of syphilitic infection 
classifies the disease as neurosyphilis irrespective of compatible 
CSF findings, the value of performing a lumbar puncture is 
controversial.19- 21 This is the first time, however, that CSF 
findings are statistically associated with change in visual acuity 
in syphilitic eye disease. The presence of neurosyphilis was 
identified as a factor followed by improvement of BCVA after 
treatment. It was subsequently associated with the presence of 
two other factors similarly associated with favourable response 
to treatment: anterior uveitis and presence of vasculitis on FA. A 
possible interpretation of these findings resides in the better 
penetration of antibiotic treatment in the context of a compro-
mised blood-ocular barrier, as is the case in anterior uveitis and 
a compromised interna! blood-retinal barrier, as identified by 
the presence of vasculitic signs, in the same manner as 
a compromised blood-cerebral barrier facilitates antibiotic 
tissue penetration in the context of bacterial meningitis.22 
In our series, there was no statistically significant difference in 
visual outcome according to the treatment between the two 
groups of patients, one treated with a classic regimen of intra-
venous penicillin and the other with a regimen of intravenous 
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ceftriaxone. Another interesting finding, which however limits 
the comparison between the above-mentioned groups, is that 
the choice of antibiotic treatment was affected by the severity of 
disease presentation, with a tendency to favour the more 
convenient regimen of ceftriaxone in cases with better BCVA at 
baseline. Our results corroborate the study by Marra et a/23 for 
the treatment of neurosyphilis, who concluded that intravenous 
ceftriaxone may be an alternative to penicillin in the treatment 
of HIV-infected patients with neurosyphilis. 
Limitations of the current study comprise its retrospective 
design and the small study sample. lt should be emphasised that 
the independence of the associations presented herein may 
not be warranted, given the inability to perform multivariate 
analysis. Consequently, the existence of underlying mutual 
confounding may not be ruled out. However, the emergence of 
statistically significant associations in this study may well point 
to their replication in future larger studies with substantial 
power. A meaningful aspect that should be declared pertains to 
the fact that generalised estimating questions with appropriate 
interaction terms could not be applied, given the small number 
of observations per ce!!. Specifically, although the association 
between eyes in bilateral cases was not statistically significant, 
the inability of the analysis to allow for correlation between eyes 
remains a limitation of the research. 
Other limitations of a retrospective analysis include 
non-standardised data collection and follow-up assessment at 
irregular intervals, albeit homogeneous in the current series with 
a single observer. Three patients were lost to follow-up, further 
limiting available data regarding change in visual acuity after 
treatment. However, the rate of loss to follow-up is not exces-
sive, bearing in mind the social stigma still associated with this 
disease. Given the above-mentioned limitations, mainly stem-
ming from the rarity and heterogeneity of the disease, further 
corroborative studies are required to confirm our findings. 
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Abstract 
Background Fluorescein (FA) and indocyanine-green angi-
ography (ICGA) may offer valuable information concerning 
disease severity and prognosis in ocular syphilis. The aim of 
the present study is to describe angiographie patterns en-
countered in the context of ocular syphilis, and to explore 
the associations between specific angiographie manifesta-
tions and severity of disease presentation, as well as disease 
evolution after treatment. 
Methods We performed a retrospective institutional study 
with the inclusion of 23 patients with ocular syphilis pre-
senting to the uveitis clinic of the Jules-Gonin Eye Hospital 
in a 10-year period. FA and ICGAwere performed following 
a standard protocol for posterior uveitis. Patterns of fluores-
cence were noted, and statistical associations between cach 
angiographie pattern and any demographic, clinical, or lab-
oratory parameter at baseline and after treatment were 
sought. 
Results The presence of any dark dots in ICGA was signif-
icantly associated with anterior uveitis (p=0.031 ). The 
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presence of hot spots in ICGA was significantly associated 
with longer duration of symptoms prior to initial visit (p= 
0.032) and with male gender (p=0.012). Weak non-
significant trends were found associating vascular staining 
in FA with anterior uveitis (p=0.066), vitritis (p=0.069), and 
younger age (p=0.061 ), as well as dise hyperfluorescence in 
FA with seropositivity for HIV (p=0.089) and macular 
edema in FA with longer disease duration (p=0.061). The 
presence of any dark dots in ICGA exhibited a weak trend of 
association with anterior uveitis and/or vitritis (p=0.079). 
Conclusions Out of the several associations identified im-
plicating specific angiographie features, we underline the 
possible role of the presence of dark dots in ICGA for 
identifying active inflammation, and the role of hot spots 
in ICGA as markers of long-standing disease. Vascular 
staining in FA appears to be more common in patients with 
severe ocular inflammation with presence of anterior uveitis 
and/or vitritis. 
Keywords Ocular syphilis · Fluorescein angiography · 
Indocyanine-green angiogrpahy 
Introduction 
Ocular involvement in the context of syphilitic infection 
presents certain particularities stemming from the close an-
atomie proximity of the eye to the central nervous system. 
Ocular syphilis is therefore classified as a variant of neuro-
syphilis, irrespective of compatible findings in the cerebro-
spinal fluid. The classical description of the clinicat course 
of syphilitic infection in three consecutive stages is less 
relevant in the presence of ocular involvement, as reflected 
in the Centers for Disease Control (CDC) guidelines for the 
management of syphilis that prompt clinicians to treat ail 
~ Springer 
cases ofocular syphilitic infection as neurosyphilis [l]. The 
value of laborato1y investigations in detennining disease 
severity and prognosis in ocular syphilis is limited. Al-
though serum VDRL titers are considered appropriate for 
evaluating disease activity and response to treatment in 
syphilis, this is less clear in the context of ocular involve-
ment, which is most common in the secondaiy, but also in 
the tertimy stage of the disease, when VDRL serology is 
almost invariably negative. Active and potentially debilitat-
ing ocular disease can therefore be accompanied by negative 
non-treponemal serology for syphilis [2]. Further laboratory 
investigations would therefore be needed to offer clues as 
regards disease severity and prognosis. The role of angiog-
raphy in detennining disease severity and in predicting 
disease evolution after treatment has not been adequately 
studied in ocular syphilis. 
Fluorescein angiography (FA) has been extensively used 
for the evaluation of ocular inflammation in the context of 
posterior uveitis [3-5]. As fluorescein sodium fluoresces in 
the wavelengths of visible light, its value is mostly limited in 
revealing pathology of the superficial structures of the fondus 
[6]. Indocyanine-green (ICG), on the other hand, fluoresces on 
the infrared spectrum, giving access to the choroidal compart-
ment through the retinal pigment epithelium. ICG leaks un-
impaired from fenestrated choriocapillaris, albeit slowly, 
gradually impregnating choroidal tissue and giving rise to 
intermediate and late choroidal background fluorescence in 
the course of the angiogram. This fluorescence and its distur-
bance from choroidal inflmmnatory lesions are the main com-
ponents studied in ICG angiography (ICGA) performed for 
posterior granulomatous uveitis [7-9]. 
FA manifestations of ocular syphilis have been reported 
in previous publications, identifying non-specific patterns of 
retinal inflammation, such as retinal and vascular staining, 
capillary leakage, macular edema, and optic dise hyperfluor-
escence [3-5]. A pattern unique to the disease has been 
described by Gass [l()], corresponding to the entity named 
syphilitic posterior placoid chorioretinitis. ICGA patterns in 
ocular syphilis have been described in a case series by Mora 
et al., emphasizing the presence of late scattered hyperfluor-
escence as characteristic to the disease [ 11]. 
The purpose of the present study is to describe angio-
graphie patterns in ocular syphilis both in fluorescein and 
ICG angiography, and to look for meaningful associations 
between specific angiographie findings and any baseline 
demographic or clinical parameter, as well as disease evo-
lution after treatment and probability for relapse. 
Methods 
We retrospectively reviewed the charts of 26 patients with 
ocular inflammation and a positive treponemal serologic test 
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for syphilis presenting to the Uveitis department of the 
Jules-Gouin Eye Hospital in the period between Januaiy 
1999 and December 2009. Inclusion criteria for this study 
were signs of uveitis compatible with ocular syphilis on 
clinical evaluation, together with a positive TPHA or 
FTA-Abs test. Medical history and serology for each 
patient were discussed with an infectious disease spe-
cialist (SG), in order to ascertain diagnosis of syphilis 
and determine stage of disease progression. All patients 
were followed by the same uveitis specialist (YGC), and 
according to official recommendations laid down for the 
management of ocular syphilis [ 1]. Treatment consisted 
of either a standard regimen of intravenous penicillin 
for neurosyphilis at a dose of 6 x 4 MO IU per day for 
14 days, or an alternative regimen of intravenous cef-
triaxone at a dose of 2 gr per day for 14 days. Inclusion 
criteria, clinical and laboratory evaluations, and manage-
ment are extensively discussed in a previous publica-
tion. Associations drawn from the same study sample as 
regards disease severity at baseline and disease evolu-
tion after treatment have also been previously reported 
[12]. Out of the 26 patients, three refused to enter into 
the proposed follow-up including fluorescein and ICG 
angiography, lumbar puncture, and visual field assess-
ment. Twenty-three patients underwent dual fluorescein 
and ICG angiography following a standard protocol for 
the evaluation of posterior uveitis at the moment of disease 
diagnosis [ 13]. The same angiographie evaluation was per-
formed a:fter the completion of a treatment cycle for ocular 
syphilis in 17 patients. 
As angiography constitutes an examination not readily 
quantifiable in clinical practice, and its interpretation remains 
to a large extent descriptive, we employed a qualitative ap-
proach to the recording of angiographie tl.ndings, noting the 
presence or absence of each characteristic pattern, but not its 
extent. This was mainly done in order to proceed to a concise, 
parsimonious statistical analysis of angiographie findings, 
given the small study sample. 
Recorded angiographie patterns in FA included macular 
edema, dise hyperfluorescence, retinal staining, vascular 
staining, retinal ischemia, pinpoint leakage, mask effect 
from preretinal hemorrhage, window defects, and fluoresce-
in leakage from choroidal or retinal neovascularization. 
Recorded angiographie patterns in ICGA included: (1) 
persistent dark dots, defined as diversely sized hypofluor-
escent areas already present in the early and intermediate 
phases of the angiogram and remaining hypofluorescent in 
the late phas~, (2) vanishing dark dots, different in that they 
became isofluorescent in the late phase of the angiogram, 
and (3) atrophie darlc dots, a sub-variant of persistent dark 
dots remaining unaltered in subsequent angiograms after 
proper antibiotic treatment. Other noted angiographie features 
included hot spots, defined as scattered hyperfluorescent foci 
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in the posterior pole or the mid-periphery in late angiographie 
frames, and fuzzy choroidal vessels observed in the intenne-
diate phase of the angiogram. 
With regard to statistical analysis of observed angio-
graphie patterns, the following angiographie features were 
set as main factors in a series of univariate comparisons: 
retinal staining, vascular staining, dise hyperfluorescence, 
and macular edema in FA, as well as the presence of any 
darlc dots and hot spots in ICGA. More specifically, the 
associations between the main factors and all registered 
demographic, clinical or laboratory parameters (ten in total) 
at baseline were thoroughly assessed. The aforementioned 
parameters included gender, age at diagnosis, unilateral or 
bilateral involvement, HIV status, duration of symptoms 
prior to initial visit, pain as a calling sign, anterior uveitis, 
vitritis, optic nerve involvement [as evidenced by a relative 
afferent pupillaty defect (RAPD), and/or optic dise swell-
ing], and relapse of inflammation after treatment. A further 
parameter, constituting an indicator of active ocular inflam-
mation, was examined against all registered angiographie 
manifestations; the presence of anterior uveitis and/or vitritis 
vs the absence of both. 
Inter-eye correlations implicating specific angiographie 
manifestations in cases with bilateral disease involvement 
were calculated in order to identify the degree of sy111111et1y 
in FA and ICGA of ocular syphilis with bilateral involve-
ment. Associations among the varions angiographie mani-
festations both in FA and in ICGA were also sought. 
Pearson's chi-square, Fisher's exact test and the Mann-
Whitney-Wilcoxon test for independent samples (MWW) 
were appropriately applied in the light of deviation from 
nonnality (as evidenced from Kohnogorov-Smirnov and 
Shapiro-Wilk tests). With regard to continuons variables, 
median values and inter-quartile ranges are reported given 
the nonparametric statistical approach adopted. The level of 
statistical significance was set to 5%. A patient-based anal-
ysis was perfonned in order to circumvent the potential 
inter-eye correlation in cases with bilateral involvcment; 
the presence of any specific angiographie manifestation in 
any particular patient was only included once in the analysis 
irrespective ofunilateral or bilateral involvement, thus elim-
inating the effect of inter-eye correlation. In simple tenns, at 
the patient-based analysis, each patient was deemed positive 
regarding an angiographie manifestation when one or bath 
eyes had exhibited the respective manifestation. Neverthe-
less, an alternative eye-based analysis was also perfonned, 
and is thoroughly presented in the Appendix, ensuring a 
comprehensive approach to available data. Given the ex-
ploratory nature of the present study, no adjustment of the 
significance level to account for multiple statistical compar-
isons was deemed to be warranted. Taking into account the 
small sample size, no multivariate analysis was performed. 
Observed associations may therefore be prone to mutual 
confounding whieh cannot be further investigated by multi-
variate analysis in the context of this study. Statistical anal-
ysis was performed with STATA 8.0 statistical software 
(Stata Corporation, College Station, TX, USA). 
Institutional Review Board (IRB)/ Ethics Committee ap-
proval of the University of Lausanne was obtained. De-
scribed research adhered to the tenets of the Declaration of 
Helsinki. 
Results 
Simultaneous fluorescein and ICG angiography were per-
fonned in 23 patients (39 eyes) at presentation, following a 
standard angiographie protocol for the evaluation of poste-
rior uveitis. The most frequent patterns of fluorescence in 
FA and ICGA are presented in Table 1. The feahu·es most 
frequently observed in FA were retinal staining of focal 
punctate retinal lesions (43.5%), followed by staining of 
retinal vessels, mainly veins (30.4%) and dise hyperfluor-
escence (30.4%) (Fig. !). Four patients presented a particu-
lar angiographie pattern consisting of hypofluorescent foci 
corresponding to the presence of chorioretinal scars, sur-
rounded by hyperfluorescent areas in the late phase, an 
aspect compatible with syphilitic posterior placoid chorior-
etinitis. ICGA features could be classified into three main 
patterns. The first pattern consisted ofhypof1uorescent cho-
roidal lesions, visible from the early and intermediate phases 
of the angiogram onwards, whieh either became isofluores-
cent in the late phases, or remained hypof1uorescent. These 
lesions, also referred to as dark dots, varied considerably in 
size, number and localisation, sharing the conunon charac-
teristie of being invisible in fluorescein angiography or 
Table 1 Findings in fluoresccin and indocyaninc-green angiography 
(11=23 and 22 patients respectively) 
Findings in fluoroangiography (11=23) 
Dise hyperfluorescence 
Macular edema 
Vascular staining 
Retinal staining and/or capillaiy leakage 
Retinal ischemia 
Normal 
Findings in ICGA (11=22) 
Dark dots 
Persistent dark dots exclusively 
Persistent and vanishing dark dots 
Hot spots 
Fuzzy choroidal vessels 
Normal 
N(%) 
7 (30.4) 
4(17.4) 
7 (30.4) 
10 (43.5) 
2 (8.7) 
2 (8.7) 
13(59.1) 
3 (13.6) 
10 (45.5) 
11 (50.0) 
5 (14.7) 
3 (8.8) 
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Fig. 1 a Fundus photograph 
depicting snowballs in the 
vitreous. b, d Extensive central 
and peripheral retinal staining 
and/or capillary leakage in FA. 
c Foci ofperipheral retinal 
vascular staining in FA 
fundoscopy, and were observed in 13 patients (59.1 %) 
(Fig. 2). The second pattern corresponded to scattered 
hyperfluorescent spots (hot spots) appearing in the late 
phases of the angiogram, in the mid-periphery and/or the 
posterior pole present in 11 patients (50%). The third pattern 
was fuzzy choroidal vessels with leakage from the interme-
diate phase of the angiogram onwards in five patients 
(14.7%). ln 13.6% of patients, the persistent variant of dark 
dots that remained unaltered in the late frames of the angio-
gram was observed, while 45.5% of patients presented both 
persistent and vanishing dark dots, the latter becoming iso-
fluorescent in late frames. Seventeen patients were submitted 
to the same angiographie investigations after the completion 
of an antibiotic treatment regimen for neurosyphilis. Where 
comparison was possible, in FA vascular staining disappeared 
after treatment in five out of seven cases (71.4 % ), dise hyper-
fluorescence in five out of seven cases (71.4%), and retinal 
staining in fouroutoften cases (40%). In ICGA, three cases of 
persistent dark dots remaining unaltered in size after treat-
ment, corresponding to chorioretinal scars, were identified. 
Hot spots disappeared in almost every case after treatment (9 
out of 11 patients, 82%) (Fig. 3). 
Out of the 23 patients, 13 had inflammatory signs 
evidenced by the presence of anterior uveitis and/or vitritis, 
whereas ten did not. Out of the latter patients, six had 
concomitant optic nerve involvement, two had posterior 
placoid chorioretinitis, three had retinal staining in FA, and 
only one had vascular staining, whereas no patient without 
anterior uveitis and/or vitritis presented with macular ede-
ma. With regard to dark dots, which were more common in 
eyes with anterior uveitis and/or vitritis though not in a 
statistically significant way, they were present in all four 
cases that presented relapse of inflammation after proper 
antibiotic treatment. 
Fig. 2 a Fundus photograph depicting normal retina. b FA of the same case revealing minimal retinal staining. c ICGA of the same case revealing 
extensive dark dots and some hot spots, invisible on both fundus photograph and FA 
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Fig. 3 a ICGA revealing hot 
spots. b Disappearance of hot 
spots after treatment 
Associations among the various angiographie manifesta-
tions in FA and ICGA are presented in the triangular Table 2. 
It is o bvious that no significant associations could be iden-
tified, other than a weak trend implicating vascular staining 
and macular edema in FA (p=0.067, Fisher's exact test), 
though not reaching statistical significance. 
Associations between the two most frequent angiograph-
ie manifestations in FA, retinal staining and vascular stain-
ing, and all registered baseline factors are presented in 
Tables 3 and 4 respectively. With regard to associations 
implicating specific angiographie features, vascular staining 
in FA exhibited a weak trend of association with vitritis (6/ 
12 patients with vitritis also exhibited vascular staining in 
FA, whereas only 1/11 patients without vitritis exhibited 
vascular staining, p=0.069, Fisher's exact test), anterior uve-
itis (5/9 patients with anterior uveitis presented with vascular 
staining vs 2/14 patients without anterior uveitis, p=0.066, 
Fisher's exact test) and youngcr age at presentation [39 .0 years 
(inter-quartile range (IQR) 9.2] for patients with vascular 
staining vs 47.8 (IQR 14.8) for those without, p=0.061, 
Mann-Whitney-Wilcoxon test), though none of the associa-
tions reached statistical significance. A strong association 
between presence of anterior uveitis and presence of vitritis 
was also identified (p=0.015, Fisher's exact test). The associ-
ation between vascular staining in fluorescein angiography 
with worse visual acuity at baseline did not reach formai 
statistical significance (p=0.072, MWW), though there was 
a significant association with improvement in visual acuity 
after treatment (p=0.005), as exhaustively described in a 
previous publication [ 12]. There was a weak trend of associ-
ation between dise hyperfluorescence in FA and seropositivity 
for HIV infection (2/2 patients with HIV also exhibited dise 
hyperfluorescence vs only 5/21 patients without HIV infec-
tion, p=0 .083, Fisher's exact test) as well as between macular 
edema in FA and longer disease duration prior to initial 
presentation [225 days (IQR 122) for patients with macular 
edema vs 12 (IQR 23) for patients without macular edema,p= 
0.061, MWW], though the associations did not reach statisti-
cal significance. As expected, dise hyperfluorescence was 
significantly associated with optic nerve involvement (p< 
0.001 ). All other associations implicating specific FA mani-
festations were non-significant. 
Associations between the presence of any darlc dots in 
ICGA and any other parameter are presentcd in Table 5. The 
presence of any dark dots was significantly associated with 
anterior uveitis (p=0.031, Fisher's), while darlc dots were 
more common in patients with antcrior uveitis and/or vitritis 
(p=0.079, Fisher's). The presence of any hot spots in ICGA 
was associated with male gender (p=0.012, Fisher's) and 
longer duration of symptoms prior to initial visit (p=0.032, 
MWW), as can be seen in Table 6. The former association 
remaincd significant even after the exclusion of patients 
positive for HIV infection (p=0.008, Fisher's). There was, 
howcver, no association between hot spots and any sign of 
active ocular inflanunation. 
In cases with bilateral disease, angiographie manifesta-
tions strongly correlated betwecn fellow eyes as follows: 
retinal staining (rho=0.854, p=0.005), vascular staining 
Table 2 Associations between the varions angiographie manifestations in FA and ICGA 
Retinal staining Vascular staining Dise hyperfluorescence Macular edema Dark dots Hot spots 
Retinal staining 
Vascular staining 0.405 
Dise hyperfluorescence 0.405 >0.999 
Macular edema 0.104 0.067 0.557 
Dark dots 0.674 0.648 0.648 0.616 
Hot spots >0.999 >0.999 >0.999 >0.999 >0.999 
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Table 3 Variables associated with retinal staining (patient-based anal-
ysis). Percentages are given with 100% corresponding to each row 
Retinal No retinal 
staining staining 
Categorical variables Freq (%) Freq (%) p 
Gender >0.999F 
Male (11=16) 7 (43.8) 9 (56.3) 
Female (11=7) 3 (42.9) 4(57.1) 
Involvement 0.402F 
Unilateral (n= 10) 3 (30.0) 7 (70.0) 
Bilateral (n= 13) 7 (53.9) 6 (46.2) 
HIV status 0.486F 
Positive (11=2) 0 (0.0) 2 (100.0) 
Negative (n=21) 10 (47.6) 11 (52.4) 
Pain as a calling sign 0.074F 
Ycs (11=8) 1 (12.5) 7 (87.5) 
No(n=l5) 9 (60.0) 6 (40.0) 
Optic neuropathy > 0.999F 
Yes (11=9) 4 (44.4) 5 (55.6) 
No(11=14) 6 (42.9) 8(57.1) 
Anterior uveitis >0.999F 
Yes (11=9) 4 (44.4) 5 (55.6) 
No (n=14) 6 (42.9) 8(57.1) 
Vitritis 0.214F 
Yes (11=12) 7 (58.3) 5 (41.7) 
No (n=ll) 3 (27 .3) 8 (72.7) 
Anterior uveitis 0.402F 
and/or vitritis** 
Yes (11= 13) 7 (53.9) 6(46.1) 
No (n= 10) 3 (30.0) 6 (70.0) 
Relapse after treatment 0.582F 
Yes (11=4) 1 (25.0) 3 (75.0) 
No (n= 15) 8 (53.3) 7 (46.7) 
Continuons variables Median Mcdian p 
(IQR) (IQR) 
Age (years) 43.0 (11.5) 47 .6 (11.8) 0.385MWW 
Duration of symptoms 36 (87) 90 (146) 0.755MWW 
prior to initial visit 
(days) 
F Fisher's exact test 
MWW Mann-Whitney-Wilcoxon test 
(rho=0.779, p=0.038), macular edema (rho=0.779, p= 
0.038), darlc dots (rho=0.810, p=0.024),and hot spots 
(rho=0.837, p=0.010). Dise hyperfluorescence did not ex-
hibit a significant correlation in cases with bilateral disease 
(rho=0.426, p=0.203), with rho values corresponding to 
Pearson's correlation coefficient and p-values deriving from 
Fisher's exact test. In the eye-based analysis, a shift was 
observed of some statistically non-significant results to-
wards statistical significance, as is thoroughly presented in 
the Appendix. 
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Table 4 Variables associated with vascular staining (patient-based 
analysis). Percentages are given with 100% corresponding to each row 
Vascular No vascular 
staining staining 
Categorical variables Freq (%) Freq (%) p 
Gender >0.999F 
Male (11=16) 5 (31.2) 11 (68.8) 
Female (11=7) 2 (28.6) 5 (71.4) 
Involvement 0.650F 
Unilateral (11= 10) 4 (40.0) 6 (60.0) 
Bilateral (n= 13) 3 (23.1) 10 (76.9) 
HIV status 0.526F 
Positive (11=2) 1 (50.0) 1 (50.0) 
Negative (11=21) 6 (28.6) 15 (71.4) 
Pain as a calling sign 0.182F 
Yes (11=8) 4 (50.0) 4 (50.0) 
No(11=15) 3 (20.0) 12 (80.0) 
Optic neuropathy > 0.999F 
Yes (11=9) 3 (33.3) 6 (66.7) 
No(11=14) 4 (28.6) 10 (71.4) 
Anterior uveitis 0.066F 
Yes (n=9) 5 (55.6) 4 (44.4) 
No (11=14) 2 (14.3) 12 (85.7) 
Vitritis 0.069F 
Yes (11= 12) 6 (50.0) 6 (50.0) 
No (11=11) l (9. l) 10 (90.9) 
Anterior uveitis 0.089F 
and/or vitritis** 
Yes (n= 13) 6 (46.1) 7 (53 .9) 
No(n=lO) 1 (10.0) 9 (90.0) 
Relapse after treatment 0.557F 
Yes (11=4) 2 (50.0) 2 (50.0) 
No (11= 15) 4 (26.7) 11 (73.3) 
Continuons variables Median Median p 
(IQR) (IQR) 
Age (years) 39.0 (9.2) 47 .8 (14.8) 0.061MWW 
Duration of symptoms 7 (147) 75 (115.5) 0.946MWW 
prior to initial visit 
(days) 
F Fisher's exact test 
MWW Mann-Whitney-Wilcoxon test 
Discussion 
We conducted this exploratmy study in search of associations 
between specific angiographie manifestations and several 
baseline demographic, clinical, or laboratory parameters. As 
regards the associations implicating specific angiographie 
manifestations in FA, only the one between vascular staining 
and improvement in visual acuity after treatment reached 
formal statistical significance. Several weak trends of associ-
ation were, however, highlighted in this analysis, specifically 
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Table 5 Variables associated with dark dots (patient-based analysis ). 
Percentages are given with 100% corresponding to each row 
Dark dots No dark 
dots 
Categorical variables Freq (%) Freq (%) p 
Gender >0.999F 
Male (11= 16) 9 (56.3) 7 (43.7) 
Female (11=6) 4 (66.7) 2 (33.3) 
Involvement 0.192F 
Unilateral (11= 10) 4 (40.0) 6 (60.0) 
Bilateral (11= 12) 9 (75.0) 3 (25.0) 
HIV status >0.999F 
Positive (11= 2) 1 (50.0) 1 (50.0) 
Negative (11=20) 12 (60.0) 8 (40.0) 
Pain as a calling sign >0.999F 
Yes (11=8) 5 (62.5) 3 (37.5) 
No (11=14) 8 (57.1) 6 (42.9) 
Optic neuropathy 0.674F 
Yes (11=9) 6 (66.7) 3 (33.3) 
No (11=13) 7 (53.9) 6 (46.1) 
Anterior uveitis 0.031F 
Yes (11=9) 8 (88.9) 1 (11.1) 
No(11=13) 5 (38.5) 8 (61.5) 
Vitritis 0.192F 
Yes (11=12) 9 (75.0) 3 (25.0) 
No(11=10) 4 (40.0) 6 (60.0) 
Anterior uveitis 0.079F 
and/or vitritis* * 
Yes (11= 13) 10 (76.9) 3 (23.1) 
No (11=9) 3 (33.3) 6 (66.7) 
Relapse after treatment 0.245F 
Yes (11=4) 4 (100.0) 0 (0.0) 
No (11=15) 8 (53.3) 7 (46.7) 
Continuons variables Median Median p 
(IQR) (IQR) 
Age (years) 45.1 (9.1) 42.2 (11.8) 0.867MWW 
Duration of symptoms 12 (147) 90 (83) 0.867MWW 
prior to initial visit 
(days) 
F Fisher's exact test 
MWW Mann-Whitney-Wilcoxon test 
between vascular staining and anterior uveitis, vitritis, anterior 
uveitis and/or vitritis, worse visual acuity at presentation, and 
younger age at presentation, as well as between dise hyper-
fluorescence and seropositivity for HIV and between macular 
edema and longer disease duration prior to the initial visit. The 
findings implicating vascular staining may point to a close 
association between these markers of active inflaimnation, 
indicating that eyes with vascular staining are more severely 
inflamed, which in turn may account for the weak trend 
towards worse BCVA at baseline in these patients. As 
Table 6 Variables associated with hot spots (patient-based analysis). 
Percentages are given with 100% corresponding to each row 
Hot Spots No Hot 
Spots 
Catcgorical variables Freq(%) Freq(%) p 
Gender* 0.012F 
Male (11=16) 11 (68.8) 5 (31.2) 
Female (11=6) 0 (0.0) 6 (100.0) 
Involvement 0.670F 
Unilateral (11=10) 6 (60.0) 4 (40.0) 
Bilateral (11= 12) 5 (41.7) 7 (58.3) 
HIV status 0.476F 
Positive (11=2) 0 (0.0) 2 (100.0) 
Negative (11=20) 11 (55.0) 9 (45.0) 
Pain as a calling sign 0.659F 
Yes (11=8) 3 (37.5) 5 (62.5) 
No (11=14) 8 (57.1) 6 (42.9) 
Optic neuropathy > 0.999F 
Yes (11=9) 4 (44.4) 5 (55.6) 
No(11=13) 7 (53.9) 6 (46.1) 
Anterior uveitis >0.999F 
Yes (11=9) 4 (44.4) 5 (55.6) 
No (11=13) 7 (53.9) 6(46.1) 
Vitritis 0.670F 
Yes (11=12) 7 (58.3) 5 (41.7) 
No(11=lO) 4 (40.0) 6 (60.0) 
Anterior uveitis 0.387F 
and/or vitritis** 
Yes (n=l3) 8 (61.5) 5 (38.5) 
No (n=9) 3 (33.3) 6 (66.7) 
Relapse after treatment 0.582F 
Yes (11=4) 1 (25.0) 3 (75.0) 
No(11=15) 8 (53.3) 7 (46.7) 
Continuons variables Median Mcdian p 
(IQR) (IQR) 
Age (years) 39.0 (18.4) 45.1 (8.9) 0.376MWW 
Duration of symptoms 90 (210) 7 (59) 0.032MWW 
prior to initial visit 
(days) 
* After the exclusion of patients with HIV infection, the association 
persists (11/15 males vs 0/5 females exhibit hot spots in ICG,p=0.008) 
F Fisher's exact test 
MWW Mann-Whitney-Wilcoxon test 
evidenced in our previous study, improvement in visual acuity 
after treatment was significantly associatcd with presence of 
vascular staining in FA, underlining the reversible nature of 
this type of ocular inflammatory reaction in the context of 
ocular syphilis [12]. The high rate of disappearance ofvascu-
lar staining in FA performed after treatment points to the same 
conclusion, indicating that vasculitis is not accompanied by 
permanent visual repercussions in ocular syphilis, when prop-
erly treated. The fact that ail patients with HIV seropositivity 
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exhibited dise hyperfluorescence in FA, illustrates a probable 
previously umecognised site of preferential posterior involve-
ment of ocular syphilis in the context of HIV co-infection. The 
potential increased prevalence of macular edema in patients 
with longer dmation of intra-ocular inflammation has been 
suspected in uveitis [14], and may point to a deleterious effect 
of persistent inflammatory stimuli, leading to graduai accu-
mulation of intraretinal fluid in the macular area. The aspect of 
"leopard spots" in fluorescein angiography described by Gass 
[1 O] in the context of syphilitic posterior placoid chorioretinitis 
as being highly indicative of syphilitic infection was also 
observed in four patients in our series. Interestingly, patients 
without anterior uveitis and/or vitritis mainly presented with 
optic nerve involvement, and to a lesser extent posterior placoid 
chorioretinitis and retinal staining, though only one su ch patient 
exhibited vascular staù1ing, and none had macular edema. 
Similar patterns in ICGA to those observed in our series 
have been described in other fonns of granulomatous pos-
terior uveitis, such as sarcoidosis and tuberculosis [15, 16], 
and are not unique to ocular syphilis. Probable interpreta-
tions for the above mentioned patterns are atrophy, fibrosis, 
or full-thiekness granuloma for persistent dark dots, partial 
thickness granuloma or delayed perfusion of choriocapillaris 
for vanishing dark dots, and choroidal vasculitis for fuzzy 
choroidal vessels. Dark dots have also been described in 
ocular sarcoidosis and ocular tuberculosis, the latter alleg-
edly being associated with more extensive and more conflu-
ent lesions [17]. Our study revealed a significant association 
between presence of darlc dots and antcrior uveitis, and a 
weak trend of association with presence of anterior uveitis 
and/or vitritis. It should be emphasized that there was a 
strong association between the presence of anterior uveitis 
and the presence of vitritis, prompting us to introduce a 
combined parameter implicating both inflammatory indiea-
tors and to test all baseline factors against this parameter as 
well. Dark dots were present in all four patients that 
exhibited relapse of inflammation after initial remission fol-
lowing proper antibiotic treatment, though no statistically 
significant association could be drawn :from such small munb-
ers. We suggest that the presence of dark dots, excluding those 
associated with atrophy, may signify active granulomatous 
posterior choroidal inflammation. Due to the small sample, 
however, we were unable to identify the specific character-
istics of dark dots, for instance size, number, and localisation, 
which are more evocative of active inflammation. 
With regard to hot spots, although they have been observed 
ù1 other granulomatous uveitis, their high prevalence in ocular 
syphilis could be characteristic to the disease. These features 
have been described in the article by Mora et al. [ 11 ], and 
probable proposed interpretations ù1clude fixing of ICG mole-
cules on active granuloma or staining of leucocytes. These 
manifestations have also been alleged to indicate active disease 
or long-standing disease. The former assumption was not, 
~ Springer 
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howeve1; statistically confirmed in the present study. On the 
contra1y, the lack of association between hot spots and any 
ocular manifestation with impmtant functional repercussions, 
such as macular edema, optic neuropathy, or anterior uveitis, 
may reveal an exclusively choroidal origin of these angiograph-
ie features. On the other hand, the identified association be-
tween the presence of hot spots and a longer duration of 
symptoms prior to the first visit may render this angiographie 
finding ù1dicative oflong-standing disease. Hot spots appeared 
to be significantly more common in male patients. This asso-
ciation, though persisting even after the exclusion of patients 
with HIV co-infection, was rather more difficult to interpret. 
Surprisingly, no association could be identified between 
various angiographie manifestations both in FA and ICGA, 
other than a weak positive trend implicating vascular staining 
and macular edema. Although both vascular staùüng in FA 
and darlc dots in ICGA appear to be more cmmnon in eyes 
with anterior uveitis and/or vitritis, they do not seem to co-
exist in the same eye. This observation, in conjunction with 
the absence of any other association between ICGA findings 
and any clinical parameter indicative of retinal inflanunation 
such as retinal stainù1g or macular edema, could justify the 
speculation oftwo morphologically and angiographically dis-
tinct patterns of syphilitic eye disease, namely a predominant-
ly choroidal versus a predominantly retinal variant. 
Inter-eye correlation of angiographie manifestations in 
case of bilateral disease involvement appears significant 
and strong as regards all main factors apart from dise hyper-
fluorescence. This analysis makes it possible to provide 
useful insight into the degree of correlation of angiographie 
findings between fellow eyes in bilateral ocular syphilis, 
which has not so far been reported. Given the high degree 
of inter-eye correlation of angiographie manifestations iden-
tified, the use of a patient-based analysis becomes even 
more appropriate in the context of the present study. 
This study has certain lùnitations ste1m11ing mainly :from its 
retrospective design and the small study sample. A further 
shortcoming lies in the loss of six patients to follow-up with 
regard to angiographie evaluation after treatment, further litn-
iting our ability to assess the effect of treatment on observed 
angiographie patterns. It should also be emphasized that given 
the small study sample, multivmiate analysis could not be 
pe1formed so as to avoid over-interpretation of available data. 
Observed associations may therefore be prone to mutual con-
founding, and their independence may not be warranted. 
We conclude, based on our findings, that angiographie 
investigation in ocular syphilis can offer valuable info1ma-
tion concerning disease severity and duration, and can even 
contribute some clues to disease prognosis. Vascular stain-
ing in FA and darlc dots in ICGA appear to be more common 
in more severely inflamed eyes with anterior uveitis and/or 
vitritis, whereas hot spots are more often present in patients 
with long-standing disease without other signs of severe 
Graefes Arch Clin Exp Ophthalmol 
inflammation. Two variants of the disease, one with predom-
inantly choroidal involvement and one predominantly retinal, 
could be hypothesized. In view, however, of the explorato1y 
nature of the current study and the above-mentioned limita-
tions, further corroborative studies are required to confirm our 
findings. Neve1theless, some earlier arbitrary hypotheses 
conceming the significance of specific angiographie features 
in granulomatous posterior uveitis were for the first time 
statistically investigated in the present study. 
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Appendix 
An eye-based analysis of registered data was perfonned in 
the service of comprehensiveness and in an attempt to 
exploit all available data. Angiographie manifestations en-
countered in FA and ICGA on an eye basis are presented in 
Table 7. With regard to associations implicating specific 
angiographie features, vascular staining in FA exhibited a 
statistically significant association with vitritis (8/19 eyes 
with vitritis also exhibited vascular staining in FA, whereas 
only 1/17 eyes without vitritis exhibited vascular staining, 
p = 0. 020), anterior uveitis (7 /15 eyes with anterior uveitis 
presented with vascular staining vs 2/21 eyes without anterior 
uveitis,p=0.019) and a weak trend implicating macular edema 
( 4/8 eyes with macular oedema vs 5/28 eyes without macular 
edema exhibited vascular staining, p=0.086), with p-values 
derived from Fisher's exact test. The association between 
Table 7 Findings in fluorescein and inclocyanine-grcen angiography 
(11=39 eyes) 
Findings in fluoroangiography (11=36) 
Dise hyperfluorescence 
Macular edema 
Vascular staining 
Retinal staining and/or capillaiy leakage 
Retinal ischemia 
Normal 
Findings in ICGA (11=34) 
Dark dots 
Persistent dark dots 
Persistent and vanishing dark dots 
Hot spots 
Fuzzy choroidal vessels 
Normal 
N(%) 
9 (25.0) 
5 (13.9) 
9 (25.0) 
15 (41.7) 
3 (6.5) 
3 (6.5) 
21 (61.8) 
4 (11.8) 
17 (50.0) 
15 (44.1) 
5 (14.7) 
3 (8.8) 
Table 8 Variabl~s asso.ciated with darlc dots (eye-based analysis). 
Percentages are g1ven w1th 100% corresponding to each row 
Dark dots No dark dots 
Categorical variables Freq(%) Freq(%) p 
Anterior uveitis 0.013F 
Yes (11= 15) 13 (86.7) 2 (13.3) 
No (11=19) 8(42.1) 11 (57.9) 
Vitritis 0.034F 
Yes (11= 19) 15 (79.0) 4 (21.0) 
No (11= 15) 6 (40.0) 9 (60.0) 
Vascular staining in FA 0.427F 
Yes (11=9) 7 (77.8) 2 (22.2) 
No (11=25) 14 (56.0) li (44.0) 
Relapse after treatment 0.066F 
Yes (11=7) 7 (100.0) 0 (0.0) 
No (11=24) 14 (58.3) 10 (41.7) 
F p-valuc derived from Fisher's exact test 
vascular staining in fluorescein angiography with worse visual 
acuity at baseline did not reach forma! statistical significance 
(p=0.072, MWW), though there was a significant association 
with improvement in visual acuity after treatment (p= O. 005), as 
exhaustively described in a previous publication [12]. Dise 
hyperfluorescence in FA was significantly associated with se-
ropositivity for HIV infection (3/3 eyes with HIV also exhibited 
dise hyperfluorescence vs only 6/33 eyes without HIV infec-
tion, p=0.012, Fisher's exact test). 
Associations betwcen the prcsence of any darlc dots in 
ICGA and any other paramcter are presented in Table 8. The 
presence of any darlc dots was significantly associated with 
Table 9 Variables associated with hot spots (eye-based analysis). 
Percentages are given with 100% corresponding to each row 
Hot spots 
Categorical variables Freq (%) 
Gender 
Male (11=23) 15 (65.2) 
Female (11=11) 0 (0.0) 
Relapse 
Yes (11=7) 1 (14.3) 
No (11=24) 11 (45.8) 
Continuons variables Median 
(IQR) 
Duration of symptoms 7 (149) 
prior to initial visit 
(days) 
No hot 
spots 
Freq (%) 
8 (34.8) 
11 (100.0) 
6 (85.7) 
13 (54.2) 
Me di an 
(IQR) 
120 (210) 
p 
<O.OOIF 
p 
0.007MWW 
Fp-value clerived from Fisher's exact test; MWW p-value derived from 
Mann-Whitney-Wilcoxon test for independent samples; IQR: inter-
quartile range 
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anterior uveitis (p=O.O 13), vitritis (p=0.034), while dark 
dots were observed in all seven eyes with relapse of inflam-
mation after proper antibiotic treatment (p=0.066). The 
presence of any hot spots in ICGA was associated with male 
gender (p<0.001) and longer duration of symptoms prior to 
initial visit (p=0.007), as can be seen in Table 9. There was, 
however, no association with relapse of inflammation after 
treatment (p=0.201). 
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